Category : Search result: pharmaceutical treatment


Cameraman's Life Changed After Tremor Surgery

After 25 years battling essential tremors, CTV News cameraman John Toman finally finds relief through groundbreaking MRI-guided focused ultrasound surgery at Toronto's Sunnybrook Hospital.

Trump Obesity Drug Deal Boosts Pharma Stocks

Major pharmaceutical giants Novo Nordisk and Eli Lilly experience significant stock surges as former President Donald Trump considers a groundbreaking obesity drug partnership, potentially revolutionizing weight loss treatment accessibility.

Manitoba Approves Life-Saving Drug for Dying Boy

A Steinbach family celebrates as the Manitoba government approves coverage for a costly medication that could save their son's life after months of uncertainty and desperate appeals.

Health Canada seizes ivermectin from BC woman

Health Canada takes decisive action against a British Columbia woman promoting ivermectin as a cancer treatment, seizing the unapproved drug and warning about serious health risks.

Calgary Toddler's Brave Fight Against Stage 4 Cancer

Meet Aurora, a courageous 18-month-old Calgary girl waging an inspiring war against stage 4 neuroblastoma. Discover her family's emotional journey and how community support is making a difference.

Leave-In Conditioner Showdown: We Crown a Winner

Discover which popular leave-in conditioner delivers salon-worthy results in our comprehensive beauty product face-off. We tested formulas for hydration, frizz control, and manageability.

Pharma Veteran Dr. Andreas Wallnofer Joins Optigo Board

Optigo Biotherapeutics strengthens leadership with renowned pharmaceutical expert Dr. Andreas Wallnofer joining its Board of Directors as the company progresses toward Investigational New Drug (IND) enabling studies.

Top FDA Drug Official Resigns Amid Federal Probe

The FDA's principal deputy commissioner, Dr. Namandjé Bumpus, resigns following federal probe into undisclosed concerns about her conduct, marking significant leadership shakeup.

Kimberly-Clark Buys Tylenol Maker in $48.7B Deal

In a landmark move reshaping the consumer healthcare landscape, Kimberly-Clark announces its acquisition of Kenvue, the company behind Tylenol and other household brands, in a staggering US$48.7 billion transaction that creates a new industry powerhouse.

Blood Pressure Medication Recall Over Cancer Risk

Health Canada issues urgent recall for specific blood pressure medications containing potentially carcinogenic nitrosamine impurity. Learn which lots are affected and what steps to take.

Boehringer Ingelheim Licenses Novel Autoimmune Treatment

Global pharmaceutical leader Boehringer Ingelheim secures exclusive license from Kyowa Kirin to develop innovative autoimmune disease treatment, targeting conditions like lupus and rheumatoid arthritis with novel therapeutic approach.

Page 4 of 4